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Background: Wounding following whole-body γ-irradiation (radiation combined injury, RCI) increases mortality.
Wounding-induced increases in radiation mortality are triggered by sustained activation of inducible nitric oxide
synthase pathways, persistent alteration of cytokine homeostasis, and increased susceptibility to bacterial infection.
Among these factors, cytokines along with other biomarkers have been adopted for biodosimetric evaluation and
assessment of radiation dose and injury. Therefore, wounding could complicate biodosimetric assessments.
Results: In this report, such confounding effects were addressed. Mice were given 60Co γ-photon radiation followed
by skin wounding. Wound trauma exacerbated radiation-induced mortality, body-weight loss, and wound healing.
Analyses of DNA damage in bone-marrow cells and peripheral blood mononuclear cells (PBMCs), changes in
hematology and cytokine profiles, and fundamental clinical signs were evaluated. Early biomarkers (1 d after RCI) vs.
irradiation alone included significant decreases in survivin expression in bone marrow cells, enhanced increases in γ-
H2AX formation in Lin+ bone marrow cells, enhanced increases in IL-1β, IL-6, IL-8, and G-CSF concentrations in
blood, and concomitant decreases in γ-H2AX formation in PBMCs and decreases in numbers of splenocytes,
lymphocytes, and neutrophils. Intermediate biomarkers (7 – 10 d after RCI) included continuously decreased γ-H2AX
formation in PBMC and enhanced increases in IL-1β, IL-6, IL-8, and G-CSF concentrations in blood. The clinical signs
evaluated after RCI were increased water consumption, decreased body weight, and decreased wound healing rate
and survival rate. Late clinical signs (30 d after RCI) included poor survival and wound healing.
Conclusion: Results suggest that confounding factors such as wounding alters ionizing radiation dose assessment
and agents inhibiting these responses may prove therapeutic for radiation combined injury and reduce related
mortality.
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Radiation injury combined with other injuries were
observed at Hiroshima and Nagasaki, Japan, where ap-
proximately 60% of victims received radiation alone with
approximately 40% of victims having other injuries con-
current with radiation injury [1,2]. After the Chernobyl
reactor meltdown, 10% of 237 victims exposed to radi-
ation received thermal burns [3]. In animals including* Correspondence: Juliann.Kiang@usuhs.edu
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reproduction in any medium, provided the ormice [4,5], rats [6,7], guinea pigs [8], dogs [9], and swine
[10,11], burns and wounds usually increase mortality
after otherwise non-lethal irradiation. In mice, irradiation
combined with wounds [4,12] decreases body weight,
increases the number of bacterial species detected in the
tissues, and reduces survival compared to wounds or ra-
diation exposure alone. Consequences of combined in-
jury include acute myelosuppression, immune system
inhibition, fluid imbalance, macro/microcirculation fail-
ure, massive cellular damage, sepsis, and disruption of
vital organ functions, leading to multiple-organ dysfunc-
tion syndrome (MODS) and multiple-organ failure
(MOF), the most frequent causes of death after com-
bined injury [13-15]. The molecular events underlyingtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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iNOS mRNA and its protein in small intestine and skin
and increased cytokine concentrations in serum [4].
These molecular changes suggest potential approaches
for the design of countermeasures and therapies as well
as possibilities for recovery from combined injury.
Whole-body irradiation induces DNA double strand
breaks that lead to ataxia telangiectasia mutated (ATM)
phosphorylation. As a result, H2AX is phosphorylated and
within seconds becomes γ-H2AX [16,17]. Phosphorylated
H2AX is proposed as a biodosimeter for total-body ra-
diation exposure [18]. One day later, whole body
irradiation results in lymphocytopenia, neutropenia,
and thrombocytopenia [19]. As γ-H2AX, the decrease
in numbers of these cells has also been used as a bio-
dosimeter for early assessment of an individual's exposure
dose and risk for morbidity and mortality [20]. Increases
in IL-6 [4,21] and Bax [17] have also been used as biomar-
kers for radiation injury [22]. However, Kiang et al. [4,17]
reported that wound trauma magnifies radiation-induced
cytokine concentrations in blood. Whether wound trauma
modified radiation-induced γ-H2AX, lymphocytopenia,
neutropenia, and thrombocytopenia was not clear. Like in
the case of cytokine increases, we hypothesized that
wound trauma enhanced γ-H2AX and hematological
responses to radiation. If this hypothesis is supported, then
the estimation of radiation dose and risk assessment using
these biomarkers will be elusive under the circumstance of
the trauma after irradiation.
Herein, we report changes in molecular and cellular bio-
markers in mice that were given 60Co-γ-irradiation fol-
lowed by skin-wound trauma, which simulates classical
combined injury [23]. Wound trauma enhanced γ-H2AX
formation in Lin+ bone marrow cells and further reduced
γ-H2AX formation in peripheral blood mononuclear cells
(PBMCs), numbers of RBCs, neutrophils, and platelets in
blood and splenocytes in spleens after irradiation. Increased
changes in blood cells and biomarkers were accompanied
by clinical signs observed at selected early-to-late time peri-
ods. Understanding the combined changes in biomarker
concentrations, blood cell numbers, and clinical signs is es-
sential for reconstructing radiation dose and calculating
risk assessment after a nuclear accident.
Results
Wounding Enhanced Radiation-Induced Mortality, body
weight loss, and water intake but slowed wound healing
As shown in Figure 1A, death from combined injury and
from radiation injury after a dose of 9.75 Gy commenced
on day 10 and day 14, respectively. On day 30, mortality
was 85% after combined injury and 35% after radiation in-
jury (P< 0.05). Wounding alone did not cause any mortal-
ity. The data suggest that wounding increased radiation-
induced mortality. Radiation dose at 9.75 Gy was LD85/30.In irradiated mice, water intake significantly decreased 1
d later, continued to decrease to 4 d, and returned to nor-
mal by 7 d. In both wounded and combined injury mice,
water intake increased the first day and persisted for 7 d;
wounded mice drank more water than combined injury
mice at 2–4 d but not 5–7 d (Figure 1B). The maximal dif-
ferences in amounts of water occurred at 4 d and were in
mL/day/mouse 3.3 ± 0.36, 1.40± 0.14, 4.25 ± 0.18, and
6.15± 0.38, for sham, irradiated, wounded, and combined
injured mice, respectively (P< 0.05).
In irradiated mice, body weight was significantly
decreased starting day 14 with an approximate rate of
−0.27 g/day and reached a nadir at day 22 with approxi-
mately 18.5% body-weight reduction. After combined in-
jury, body weight significantly decreased after day 7 with
an approximate rate of −0.64 g/day and reached a nadir
at day 14 with over 20% of body-weight reduction.
Wounding alone did not alter body weight (Figure 1C).
In mice subjected to wounding only, the wound closed
within 15 d with an approximate rate of 19 mm2/day.
When mice were subjected to combined injury, the
wound took ≥30 d to close in surviving animals with an
approximate rate of 8 mm2/day (Figure 1D).
Wounding Increased Radiation-Induced γ-H2AX formation
in Lin+ bone marrow cells
Phosphorylation of histone protein H2AX on serine 139
(γ-H2AX) occurs at sites flanking DNA double-strand
breaks [24]. Ataxia telangiectasia mutated (ATM) protein
kinase autophosphorylates and phosphorylates histone
H2AX (γ-H2AX) in response to DNA double-strand
breaks [25]. Radiation increases γ-H2AX formation [26],
which is a reflection of DNA double-strand breaks [24].
To determine if wounding altered the radiation-induced
γ-H2AX increase, femoral bone marrow cells were har-
vested from mice 1 d after sham-treatment, wounding, ra-
diation injury, and combined injury and separated into
lineage-positive (Lin+) cells, and the lineage-negative (Lin−)
cells, including Lin−-Sca1+-c-Kit+ cells, Lin−-Sca1−-c-Kit+
cells, Lin−-Sca1+-c-Kit−, and Lin−-Sca1−-c-Kit−. Because ra-
diation at 9.75 Gy killed almost all of bone marrow cells, in
order to collect sufficient bone marrow cells for γ-H2AX
measurements, mice received 8.5 Gy, a LD0/30 dose to RI
mice and a LD15/30 dose to CI mice. As shown in Figure 2,
radiation significantly increased γ-H2AX formation in all
five types of cells, whereas wounding alone did not. Never-
theless, wounding further increased radiation-induced γ-
H2AX formation only in Lin+ cells by 64% (Figure 2A) but
not in Lin−-Sca1+-c-kit+ cells (Figure 2B) and Lin−-Sca1−-c-
Kit+ cells (Figure 2C). In contrast, wounding reduced
the radiation-induced increases in γ-H2AX formation
in Lin−-Sca1+-c-Kit− cells by 36% (Figure 2D) and
Lin−-Sca1−-c-Kit− cells by 58% (Figure 2E), indicating
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Figure 1 Wounding enhanced the radiation-induced mortality, water intake, and body weight loss, and delayed wound healing rate.
N=20 mice per group. (A) Wounding reduced 30-day survival after irradiation. *P< 0.05 vs. sham, wound, and CI groups; **P< 0.05 vs. sham,
wound, and RI groups. (B) Wounding and/or radiation increased water consumption during the first 6 d. Radiation alone inhibited water
consumption, which returned to normal baseline at 7 d. *P< 0.05 vs. sham, wound, and CI groups; **P< 0.05 vs. sham, RI, and CI groups;
***P< 0.05 vs. sham, RI, and CI groups. (C) Wounding accelerated radiation-induced body weight loss. *P< 0.05 vs. sham, wound, and CI groups;
**P< 0.05 vs. sham, wound, and RI groups. (D) Radiation delayed wound healing. *P< 0.05 vs. wound group. RI: Radiation injury at 9.75 Gy; CI:
combined injury.
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in Lin− c-kit− cells.
Survivin is a protein that regulated by p53 [27] and
inhibits Bax and Fas [28,29]. To determine whether ion-
izing radiation alone or combined with wound trauma
could alter survivin, survivin from bone marrow cells
collected from mice exposed to 9.75 Gy was measured
using western blotting. Figure 2F shows that ionizing
radiation alone suppressed survivin and wound trauma
did not further its suppression, suggesting that survivin
but not γ-H2AX would be a dependable biomarker
for radiation dose assessment under conditions of ei-
ther radiation alone or radiation combined with
wound trauma.Wounding decreased radiation-Induced γ-H2AX formation
in PBMCs
Like Lin+ bone marrow cells, radiation significantly
increased γ-H2AX formation as shown in Figure 3. Un-
like Lin+ bone marrow cells, wounding diminished this
increase by 48% 1 d (Figure 3A) and by 35% 10 d (Fig-
ure 3B) but not after 30 d (data not shown). Wounding
alone did not alter the baseline of γ-H2AX formation.
Wounding further reduced radiation-induced splenocyte
decreases
The spleen assists in immune function by degrading old
red blood cells, storing healthy blood and assisting in de-
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Figure 2 Combined injury modulated γ-H2AX formation more than radiation injury and suppressed survivin 1 d post-irradiation and/or
wounding in bone-marrow cells. N= 8 mice per group. For panels A, D, and E: *P< 0.05 vs. sham, wounded, and CI groups; **P< 0.05 vs. sham,
wounded, and RI groups. For panels B and C: *P< 0.05 vs. sham and wounded groups (W: wounded; RI: radiation injury at 8.5 Gy; CI: combined
injury). For panel F: *P< 0.05 vs. sham and wounded groups (RI: radiation injury at 9.75 Gy; CI: combined injury).
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1 d post-irradiation, whereas combined injury further
reduced splenocyte numbers by 34% at 1 d. This difference
in cell loss between radiation injured mice and combined
injured mice was not observed at 7 d (data not shown).*
**
A
1 day after irradiation
Figure 3 Combined injury attenuated radiation-induced increases in γ
mice per group; *P< 0.05 vs. sham, wounded, and CI groups; **P< 0.05 vs.
8.5 Gy; CI: combined injury.Wounding further reduced radiation-induced white blood
cell decrease
It is well known that radiation reduces the circulating
white blood cell (WBC) population. In this study, radiation
injury at 9.75 Gy resulted in a significant reduction of total*
**
B
10 days after irradiation
-H2AX formation in peripheral blood mononuclear cells. N= 8
sham, wounded, and RI groups. W: wounded; RI: radiation injury at
**
*
Figure 4 Combined injury reduced numbers of splenocytes
more than radiation injury 1 d post-irradiation and/or
wounding. N= 4 mice per group. *P< 0.05 vs. sham, wounded, and
CI groups; **P< 0.05 vs. sham, wounded, and RI groups. W;
wounded; RI: radiation injury at 9.75 Gy; CI: combined injury.
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irradiation (Figure 5A-D). Numbers of total WBCs and
neutrophils, but not lymphocytes and monocytes, were






Figure 5 Combined injury reduced numbers of white blood cells mor
mice per group. For panels A and C, *P< 0.05 vs. sham, wounded, and CI g
D, *P< 0.05 vs. sham and wounded groups. Panels E and F: not significant.respectively (Figure 5A and C). However, eosinophils
(Figure 5E) and basophils (Figure 5F) were not signifi-
cantly altered by either wounding, radiation injury, or
combined injury. The combined-injury-induced further
cell reduction at 1d was not observed at 7d (data not
shown).
Wounding further reduced radiation-induced platelet
decrease
Bone marrow is a radio-sensitive tissue. Platelet produc-
tion is derived from megakaryocytes in bone marrow. In
a previous study we found that the number of platelets
decreased to a nadir of 30,000/μl between 8 and 10 days
after 6.5 Gy 60Co-gamma photons [30]. In this present
study, the numbers of platelets in blood of wounded, ra-
diation injured, and combined injured mice at 1 d were
not significantly different from those in sham-mice (data
not shown). The number of platelets in blood was
increased significantly 7d after wounding to 1765 ± 167 x
103 cells/μl. In contrast, platelet numbers decreased after
irradiation alone to 125 ± 86 x 103 cells/μl. However,
platelet numbers decreased even further after combined
injury to 41 ± 15 x 103 cells/μl (Figure 6A).
Unlike platelets, Figure 6 shows that 1 d (data not
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Figure 6 Combined injury reduced numbers of platelets more than radiation injury 7 d post-irradiation and/or wounding. N= 6 mice
per group. For panel A, *P< 0.05 vs. sham, RI, and CI groups; **P< 0.05 vs. sham, wounded, and CI groups; ***P< 0.05 vs. sham, wounded, and RI
groups. For panel B, *P< 0.05 vs. sham group. W: wounded; RI: radiation injury at 9.75 Gy; CI: combined injury.
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Figure 7 Combined injury increased radiation-induced cytokine elevation. N= 6 mice per group. For panel A, at 1 day: *P< 0.05 vs. sham
and RI groups; at 7 days: *P< 0.05 vs. sham, RI, and CI groups; **P< 0.05 vs. sham, wounded, and RI groups. For panel B, at 1 day: *P< 0.05 vs.
sham and RI groups; at 7 days: *P< 0.05 vs. sham and CI groups; **P< 0.05 vs. sham, wounded, and RI groups. For panel C, at 1 day: *P< 0.05 vs.
sham and wounded groups; at 7 days: *P< 0.05 vs. sham and CI groups; **P< 0.05 vs. sham, wounded, and RI groups; at 30 days: *P< 0.05 vs.
sham, RI, and CI groups; **P< 0.05 vs. sham and wounded. For panel D, at 1 day: *P< 0.05 vs. sham and RI groups; at 7 days: *P< 0.05 vs. sham,
RI, and CI groups; **P< 0.05 vs. sham, wounded, and CI groups; ***P< 0.05 vs. sham, wounded, and RI groups; at 30 days: *P< 0.05 vs. sham and
wounded. W; wounded; RI: radiation injury at 9.75 Gy for 1 day and 7 days and 9.25 Gy for 30 days; CI: combined injury.
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wounding and radiation injury, but the number of RBCs at
7 d but not 1 d (data not shown) in combined injured-
mice was significantly lower than in the sham group, but
not in wound and radiation injured groups (Figure 6A).
Wounding enhances radiation-induced cytokine
concentrations
Because radiation causes a short-term inflammatory re-
sponse by increasing concentrations of proinflammatory
cytokines in plasma [31-33] and spleen [34,35], cytokines
have been considered as early biomarkers for radiation in-
jury [21]. As shown in Figure 7, combined injury but not
radiation injury induced increases in IL-1β by 98%, IL-
6 by 44-fold, and G-CSF by 123-fold 1 d post-irradi-
ation and enhanced radiation-induced increases further
by 20-fold, 31-fold, and 84-fold, respectively, 7 d post-
radiation, whereas IL-8 was increased by both RI and
CI to the same level by 41-fold 1d after irradiation,
and by only CI by 48-fold 7 d after irradiation. Thirty
days later, only IL-8 and G-CSF remained above the base-
line in combined injured mice, but the increases were not
different from those induced by radiation alone.Discussion
Internationally general guidelines for early medical diagno-
sis and biodosimetric assessment of individuals exposed to
radiation are well established [36]. These approaches usu-
ally apply for assessment of whole-body irradiation alone.
However, frequently, individuals involved in radiation acci-
dents and cancer radiation-therapy patients may experi-
ence a secondary or tertiary tissue injury. Research efforts
for biodosimetry need to be developed and validated for
assessment under combined injury with other confound-
ing factors. Since time-course studies exhibited changes in
blood cell numbers, cytokine concentrations in blood, pro-
tein phosphorylation in bone marrow cells and PBMCs,
and clinical signs at various time points after combined in-
jury, we assigned these changes for combined injury into
three general periods: early, intermediate, and delayed ex-
pression. Most important, changes in molecular and
genetic biomarkers in blood and bone marrow were sig-
nificant after combined injury.
In bone marrow cells, combined injury increased
γ-H2AX formation more than radiation alone 1d post-ir-
radiation and/or wounding in Lin+ bone-marrow cells.
Wounding alone had no impact on this biomarker, sug-
gesting that wounding does not induce double-strand
breaks in DNA and that the biomarker, γ-H2AX, is spe-
cific to radiation and combined injury (Figure 2). It is
not clear why wound trauma enhanced radiation-
induced γ-H2AX formation in these cells. It warrants
further studies.The enhancement occurred only in Lin+ bone-marrow
cells but not Lin− bone-marrow cells. Instead, wounding
attenuated the radiation-induced γ-H2AX formation in
Lin−-Sca1+-c-kit− and Lin−-Sca1−-c-kit− cells. It is not
clear why presence or absence of c-kit receptors on bone
marrow cells varied in response to combined injury. Like
Lin−-c-kit− bone-marrow cells, wounding attenuated the
radiation-induced γ-H2AX formation 1 d and 10 d in
PBMCs (Figure 3). Interestingly, both RI and CI signifi-
cantly suppressed survivin, a protein regulated by p53
[27] and inhibiting Bax, Fas, and caspases [28,29], to a
similar level. This observation made survivin potentially
become a dependable biodosimeter under radiation com-
bined with wound trauma for radiation dose assessment.
Early changes in γ-H2AX formation were also accom-
panied with reductions in numbers of splenocytes, lym-
phocytes, and neutrophils (Figures 4–5). Although bone
marrow cells were altered in response to wounding, the
changes in these cells did not coincide with the increase
in Fms-related tyrosine kinase 3 (Flt-3) ligand concentra-
tions in irradiated and combined injured mice. Flt-3 lig-
and is a hematopoietic four-helical-bundle cytokine. It is
structurally homologous to stem cell factor (SCF) and
colony stimulating factor 1 (CSF-1). It is a member of a
small family of growth factors that stimulate the prolif-
eration of hematopoietic cells. CD135 is its receptor and
stimulates B- and T-cell proliferation and maturation
[37]. In synergy with other growth factors, Flt-3 ligand
stimulates the proliferation and differentiation of various
blood cell progenitors [38,39]. Flt-3 ligand plasma con-
centrations are inversely correlated with either the fre-
quency of colony-forming cells in the bone marrow or
the extent of bone marrow aplasia postirradiation
[38,40,41]. This laboratory previously reported that radi-
ation increased Flt-3 ligand concentrations 3-fold 1 d
post-irradiation, whereas subsequent wounding did not
further increase it [42], indicating that wounding is not
associated with bone marrow aplasia. The result sug-
gested that Flt-3 ligand is a dependable biodosimeter
under radiation combined with wound trauma as well
for radiation dose assessment.
Intermediate biomarkers for combined injury are reduc-
tions of the numbers of RBCs and platelets (Figure 6). The
latter was induced by radiation injury to bone marrow as
shown previously [30]. Wounding used remaining platelets
in the clotting process to reduce bleeding thereby decrease
the number even further after irradiation. The reduction
occurred 7 d (but not 1 d) after combined injury, whereas
wounding alone induced an increase in numbers of plate-
lets. The difference in early biomarkers such as numbers
of WBCs, neutrophils, and splenocytes was no longer
measurable in combined injured mice after Day 7. The de-
gree of reduction of these cells was similar between radi-
ation alone and combined injury.
Table 1 Combined injury signs compared to radiation
injury signs
Early signs More water intake
Greater decreases in numbers of total WBCs
More γ-H2AX formation in Lin+ bone-marrow cells
Similar decreases in survivin protein






Greater decreases in numbers of RBCs and platelets
Less γ-H2AX formation in PBMCs
Greater increases in serum concentrations of IL-1β, -6, -8,
and G-CSF
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fied increases in IL-1β, IL-6, IL-8, and G-CSF in serum on
day 1, whereas radiation-induced cytokine changes in
serum occurred only in IL-8 (Figure 7). The synergistic
increases in IL-1β, IL-6, IL-8, and G-CSF concentrations
in serum were greater on 3–7 d [4] than those increases
observed on 1 d. Combined injury had a greater effect on
concentrations of these cytokines than did radiation alone.
A similar synergy in IL-6 concentrations was observed in
combined radiation and burn mouse model [43].
The increased concentrations of IL-1β, IL-6, IL-8, and
G-CSF 7 days after combined injury were caused by the
combined injury-induced sepsis due to the bacterial
entry from the broken GI barrier and the skin-wound
site. The sepsis began 3 days after combined injury [4].
Therefore, these magnified increases were not observed
1 day but became statistically significant 7 days after
combined injury compared to wound trauma alone [4].
These increases in serum cytokines are a natural re-
sponse to injury in an attempt to control damage to tissue
and restore homeostasis. IL-1β and IL-6 are proinflamma-
tory but the usual responding cells have been killed by ra-
diation. G-CSF promotes hemopoietic differentiation of
progenitor cells into granulocytic cells, including neutro-
phils, but the progenitor cells have also been killed. IL-8
promotes chemotaxis of neutrophils to a site of injury but
there are no neutrophils to respond. So, these increases in
serum cytokines are ineffective while they indicate a re-
sponse to injury early after injury. Therefore, increasing
values during early hours and days following combined in-
jury may provide a strong indication for intensive therapy.
Thirty days after irradiation or combined injury, IL-8 and
G-CSF concentrations in the serum remained above the
baseline. Perhaps continuously increasing high concentra-
tions of either IL-8 or G-CSF in the blood indicate indivi-
duals that are likely to survive but other biomarkers are
needed for definitive early prognosis.
Skin-wound closure (as an indicator of healing) is
known to depend on the dose of radiation [44,45]. Thus,
wound closure is an indicator for the extent of tissue in-
jury and healing rate in combined injured mice. In non-
irradiated mice, skin-wounds healed completely within
15 days. In combined injured mice given a dose of
9.75 Gy, more than 30 days were needed for complete
closure in survivors, which indicated a delayed healing
rate. (Figure 1D).
The nadirs of body weight loss may also be a useful
parameter for distinguishing radiation injury from com-
bined injury. In our study, the nadirs for the body weight
in radiation-injured mice and combined-injured mice
were 22 days and 14 days, respectively (Figure 1C).
A combination of biomarkers and clinical signs and
symptoms could be useful for determining and differen-
tiating the contribution of dose of radiation to survivalwith or without tissue injury. This is a continuing work-
ing hypothesis. Blood components and serum cytokine
concentrations are valuable biomarkers of tissue injury
and should be closely monitored for establishing radi-
ation dose assessment combined with wounding. Valid-
ation of selected blood biomarkers for prognosis of
radiation injury and dose assessment await further rigor-
ous specificity and sensitivity studies. These studies
should use appropriate animals, when possible, and ad-
dress potential relevant confounding effects, for instance,
age, gender, chronic disease, burn, inflammation, wound-
ing, and partial-body exposure.
This current study (Figure 1A) corroborates that radi-
ation combined with wound trauma potentiates lethality
compared to radiation alone [5]. Studies with several ani-
mal species have shown similar results [6-10,33,34]. In
addition to lethality, a synergistic effect on behavior or
emesis after radiation combined with daily exhaustive ex-
ercise, continuous exposure to cold (6°C), or continuous
exposure to high altitude (15,000 feet) are documented
[46]. Furthermore, Kato and Schull [47] reported an
increased mortality rate from lung cancer related to
cigarette smoking in atomic-bomb survivors. It would be
of interest to investigate whether a similar finding be-
tween acute and long-term effects after radiation injury
combined with wound trauma is present.
Failure to thrive early after injury indicates a need to ini-
tiate aggressive early therapy. Combined injured mice
drank more water than sham-treated mice. In contrast, ra-
diation alone suppressed water consumption. Hypodipsia
was observed 1 day after irradiation and lasted for 6 days
(Figure 1B). Then, the volume of daily water intake in both
irradiated and combined injured mice returned to the
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daily water consumption volume distinguishes radiation
injury alone from combined injury and, so, might be a
good indicator for prognosis. The return to normal con-
sumption of food and water that is reflected in increased
body weight may be a good prognostic indicator of recov-
ery from radiation injury and combined injury. Table 1
summarizes the signs.
In summary, we demonstrated for the first time that
responses of selected biomarkers to radiation were chan-
ged significantly by subsequent wounding shortly after ir-
radiation. The early biomarkers (1 d after injury) included
enhanced responses in γ-H2AX formation in Lin+ bone
marrow cells, numbers of splenocytes, lymphocytes, and
neutrophils, and concentrations of IL-1β, IL-6, IL-8, and
G-CSF in blood. Increased water consumption by mice
also occurred early after combined injury. The intermedi-
ate biomarkers (7 – 10 d after injury) included continued
large increases in IL-1β, IL-6, IL-8, and G-CSF concentra-
tions in blood and reduced γ-H2AX formation in PBMCs.
Large decreases in body weight and decreased wound
healing were notable during the intermediate period. Al-
though continued elevation of IL-8 and G-CSF concentra-
tions and slow wound healing persisted at 30d, other
biomarkers in the same mice had recovered to normal
values in the surviving mice.
Conclusion
The severity of injury manifested immediately after ir-
radiation combined with wound injury, and prognosis
for its survival depends upon a complex matrix of factors
including numbers of circulating blood cells, molecular
biomarkers, and other physiological endpoints. Changes
in the parameters measured in this study support not only
early intervention with intensive therapy to strengthen
chances of survival but also the concept of successful ther-
apy, which may be adjusted to conserve critical medical
resources. Biomarkers such as levels of survivin in bone
marrow cells and Flt-3 ligand in serum are dependable
ones for radiation dose assessment under either radiation
alone condition or radiation combined with wound trauma
condition. Furthermore, the greater amount of water con-
sumption, the high speed of wound healing rate, the low
levels of serum cytokine concentrations can distinguish the
wounded subjects from those also exposed to irradiation.




B6D2F1/J female mice were purchased from Jackson La-
boratory (Bar Harbor, ME) and used when 12–20 wk old.
Male mice were not used in this study because of aggres-
sion, which in these experiments could lead to furtherdamage to wound sites and enhanced infection. All mice
were randomly assigned to experimental groups. Eight
mice were housed per filter-topped polycarbonate cage
(MicroIsolator) in conventional holding rooms. Rooms
were provided 20 changes of 100% fresh air per h, condi-
tioned to 72±2°F with relative humidity of 50± 20%. Mice
were maintained on a 12-h 6 am light/6 pm dark, full-
spectrum-light cycle with no twilight. Research was con-
ducted in a facility accredited by the Association for As-
sessment and Accreditation of Laboratory Animal Care-
International (AAALAC-I). All procedures involving ani-
mals were reviewed and approved by the AFRRI Institu-
tional Animal Care and Use Committee. Euthanasia was
carried out in accordance with recommendations [48,49]
and guidelines [50].
Prior to experiments, hair of the dorsal surface of mice
was removed under anesthesia (methoxyflurane inhal-
ation) using electric clippers. Mice were placed in well-
ventilated acrylic restrainers for irradiation or sham treat-
ments. Within 1 h after irradiation or sham irradiation,
mice were anesthetized by methoxyflurane inhalation, and
wounding or sham wounding was performed. All mice
received an i.p. injection of 0.5 ml sterile isotonic 0.9%
NaCl as fluid therapy immediately after sham handling, ir-
radiation, and/or wounding. After fluid therapy, mice were
returned to their original cages. After irradiation and/or
wounding, their water consumption for the first 7 days,
body weights, wound closure, and survival for 30 days
were measured as described previously [4].Irradiation
Mice were given selected doses of whole-body 60Co γ-
photon radiation delivered at a dose rate of 0.4 Gy/min
bilaterally. Dosimetry was performed using the alanine/
electron paramagnetic resonance system. Calibration of
the dose rate with alanine was directly traceable to the
National Institute of Standards and Technology and the
National Physics Laboratory of the United Kingdom.
Mice treated as shams were treated identically to other
groups but received no radiation and were not wounded.Skin wounding
Within 1 h after irradiation, mice were anesthetized by
methoxyflurane prior to wounding. A non-lethal total
body surface area (TBSA) wound was administered ap-
proximately 20 mm from the occipital bone and between
the scapulae using a stainless steel punch on a Teflon-
covered board cleaned with 70% alcohol before each use.
The panniculus carnosus muscle and overlying skin (ap-
proximately 24 mm in length and about 15 mm in
width) were removed. Mice receiving only sham treat-
ments were manipulated identically to other groups but
received no radiation or wounding. Mice receiving only
Kiang et al. Cell & Bioscience 2012, 2:20 Page 10 of 12
http://www.cellandbioscience.com/content/2/1/20wounds were also treated identically to other groups but
received no radiation.
Collection of bone marrow and blood
In a separate experiment, mice were anesthetized with
methoxyflurane 1, 10, and 30 d post-radiation and/or
wounding. Blood was collected through cardiac puncture.
Mice were euthanized and bone marrow cells from femurs
were collected. Samples at the 30-d time point were col-
lected from mice at the end of the survival experiment.
Peripheral blood mononuclear cell staining
Blood samples were collected 1 d and 10 d after RI and
CI. According to the manufacturer's protocol provided
by Invitrogen, whole blood samples were incubated with
ACK lysing buffer (Invitrogen) at 37°C for 15 min to re-
move red blood cells. Then by following the manufec-
turer’s protocol provided by BD Biosciences, obtained
peripheral blood mononuclear cells (PBMCs) were
washed with PBS, incubated with 1 μl of Live/Dead Fix-
able Dead Cell Stain-Near-Infrared (Invitrogen) and
<1 μg/ml of Mouse Fc Block (BD Biosciences) in PBS
on ice for 30 min, washed with PBS, incubated on ice
for 30 min with anti-mouse-CD45-allophycocyanin (e-
Bioscience), permeabilized and stained with perm/wash
buffer (BD Biosciences), containing 7%v/v anti-phospho-
H2AX-FITC (Millipore) and Mouse Fc block (BD Bios-
ciences) on ice for 20 min, and washed with 1x perm/wash
buffer (BD Biosciences).
Bone marrow cell staining
According to the manufacturer’s protocol provided by
BD Biosciences, approximately 1 × 106 total bone marrow
cells were incubated with 1 μl of Live/Dead Fixable Dead
Cell Stain-Near-Infrared (Invitrogen) and <1 μg/ml of
Mouse Fc Block (BD Biosciences) in PBS on ice for
30 min and washed with PBS. The cells were then incu-
bated with a cocktail of Mouse Hematopoietic Lineage
Flow Cocktail-eFluor450 (e-Bioscience), anti-mouse-c-
kit-Cy5(e-Bioscience), and anti-mouse-Sca-1-phycoeryth-
rin-Cy5.5(e-Bioscience), and then washed again with
PBS, fixed with 1.5% paraformaldehyde for 20 min on
ice, washed with PBS, permeabilized and stained with
perm/wash buffer (BD Biosciences), containing 7% v/v
anti-phospho-H2AX-FITC (Millipore) and Mouse Fc
block (BD Biosciences), and washed with 1x perm/wash
buffer (BD Biosciences).
Flow cytometry for γ-H2AX measurement
Stained blood and bone marrow cells with no less than
5,000 cells were analyzed on a LSR II cytometer (BD
Biosciences) equipped with 407, 488 and 633 nm lasers,
emission filters for near-infrared, FITC, PE-Cy5.5, APC,
and Cy5, and a high-throughput sampler in BiomedicalInstrumentation Center (BIC) in USUHS. Data were
analyzed with FACSDiva software (BD Biosciences).
Analyses were performed at the Uniformed Services
University of the Health Sciences Flow Cytometry
Core Facility, Bethesda, Maryland.Assessment of blood cell profile in peripheral blood
The ADVIA 2120 Hematology System (Siemens, Deerfield,
IL) was employed for assessment of blood samples col-
lected 1 d and 7 d after RI and CI. Differential analysis was
conducted using the peroxidase method and the light scat-
tering techniques recommended by the manufacturer.Splenocyte measurements
Spleens were collected from each mouse 1 d and 7 d
after RI and CI. Each specimen was mashed in a cell
strainer (BD Falcon, Bedford, MA) with 1x HBSS. Sple-
nocytes in the buffer were washed with 1x ACK lysis
buffer (Invitrogen), vortexed with a shaker, and centri-
fuged at 800 xg. Splenocytes were collected and counted
using a hemocytometer.Serum cytokine measurements
Cytokines in serum were measured in mice 1, 7 d, and
30 d after sham treatment, wounding, RI, or CI (n = 6
mice per group at each time point). Whole blood (0.7 –
1 ml) was collected by cardiac puncture from mice
anesthetized with methoxyflurane. Serum was separated
by centrifugation at 1000xg and stored at −70°C until
assayed. Cytokine protein concentrations in serum were
analyzed using the Bio-Plex TM Cytokine Assay (Bio-Rad;
Hercules, CA) to analyze a panel of 23 cytokines (Mouse
Cytokine 23-Plex; Bio-Rad) following the manufacturer’s
directions. Briefly, sera from each animal (6 animals per
group) were diluted fourfold and examined in duplicate.
Data were analyzed using the LuminexW 100™ System
(Luminex Corp., Austin, TX), quantitated using MiraiBio
MasterPlexW CT and QT Software (Hitachi Software En-
gineering America Ltd.; San Francisco, CA), and concen-
trations expressed in pg/ml. The cytokines analyzed
were: IL-1α, IL-1β, IL-2, IL-3, IL-4, IL-5, IL-6, IL-8 (i.e.
KC), IL-9, IL-10, IL-12(p40), IL-12(p70), IL-13, IL-17,
Eotaxin, G-CSF, GM-CSF, IFN-γ, MCP-1, MIP-1α, MIP-
1β, RANTES, and TNF-α.Endotoxin measurements
All materials including water, phosphate saline buffer,
and saline, which were used for evaluation of test sam-
ples collected from mice, were tested with EndosafeW
(Charles River Endosafe, Charleston, SC) to ensure that
they were endotoxin-free according to the manufac-
turer’s procedure.
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Data are expressed as the mean± s.e.m. For each experi-
ment, 6 mice per group were tested on an individual basis.
Each biochemical assay was performed in duplicate while
the blood cell differentiation test was performed once.
One-way ANOVA, two-way ANOVA, studentized-range
test, Bonferroni’s inequality, and Chi-square test were used
for comparison of groups, with 5% as a significant level.
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